Press Release

Point-of-Care Biopsy Market Set to Nearly Double by 2032, Driven by Demand for Rapid Diagnostics

Pune, India | November 24, 2025
Global Data Route Analytics

The global point-of-care biopsy market, valued at USD 3.4 billion in 2024, is poised for accelerated growth, projected to reach nearly USD 6.6 billion by 2032. This impressive CAGR of 14.3% is driven by the global healthcare industry’s shift toward on-the-spot diagnostics, enabled by advancements in portable biopsy instruments and real-time imaging technologies.

Amidst the rising incidence of cancer worldwide, healthcare providers are increasingly adopting point-of-care (PoC) biopsy solutions for minimally invasive, rapid, and decentralized diagnosis. These technologies are particularly gaining momentum across hospitals, diagnostic labs, specialty clinics, and ambulatory surgical centers, where early detection and efficiency are paramount.

For a free sample of the report, please contact us here: 

https://globaldatarouteanalytics.com/report/123/global-point-of-care-biopsy-market/download

Market Segmentation Highlights:

  • By Product Type: Needle-Based Biopsy Instruments, Vacuum-Assisted Systems, Core & Fine Needle Devices, Surgical Equipment, Disposable & Reusable Tools
  • By Technique: Ultrasound-Guided, MRI-Guided, CT-Guided, Stereotactic, Image-Guided, and Manual Biopsies
  • By Application: Most prominent in breast, lung, prostate, colorectal, and skin cancers
  • By End-Use: Key demand from hospitals, diagnostic labs, ASCs, homecare settings, and research institutes
  • By Region: Strong adoption in North America, Europe, and Asia-Pacific, with emerging opportunities in Latin America and MEA

The integration of AI-based imaging systems, disposable biopsy tools, and the rise of home-based diagnostic care are expected to further expand the market's reach in the coming years.

For any inquiry related to this report, please click here:

https://globaldatarouteanalytics.com/report/123/global-point-of-care-biopsy-market/inquiry

Key Companies Shaping the Market:

The report profiles 15+ major players actively driving innovation and strategic partnerships in the global PoC biopsy market:

  • BD (Becton, Dickinson and Company)
  • Danaher Corporation (Leica Biosystems)
  • Hologic, Inc.
  • Medtronic plc
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Stryker Corporation
  • Cook Medical LLC, and others including Argon Medical, Devicor, Bioncise, Zamar Care, Scion Medical, and INRAD

These companies are heavily investing in portable diagnostic platforms, real-time biopsy evaluation, and multimodal imaging, reinforcing their market positions and expanding their offerings for cancer diagnostics.

Future Outlook:

With healthcare systems globally emphasizing early detection, reduced turnaround times, and point-of-care accessibility, the biopsy market is entering a transformative phase. Stakeholders investing in next-gen biopsy techniques, portable imaging integration, and AI-guided diagnostics will be best positioned to capitalize on this high-growth segment through 2032.

For discounts related to this report, explore here: 

https://globaldatarouteanalytics.com/report/123/global-point-of-care-biopsy-market/discount

About Global Data Route Analytics

Global Data Route Analytics is a market research and consulting firm that provides businesses with data analysis, market forecasts, and tailored reports across various industries. The company uses advanced data analysis techniques, proprietary data, and an expert team to help clients understand market trends, make informed decisions, and develop strategies. They focus on delivering customized solutions, competitive intelligence, and growth strategies to help businesses succeed in their respective markets.

Media Contact:
Srushti Tungar
Global Data Route Analytics

Latest Press Release